UnitedHealth Expects $6B Medicare Overhaul Impact, Targets $17.75 EPS
Medicare Advantage payment revisions have reduced UnitedHealth Group's revenue by billions, with an expected $6 billion impact on 2026 results due to exclusions in risk-adjustment reimbursements for diagnoses. The insurer plans cost reductions across Optum Health—network narrowing, EMR consolidation and asset divestitures—while targeting adjusted earnings above $17.75 per share.
1. Medicare Overhaul Impact
UnitedHealth Group is grappling with a $6 billion headwind from revised Medicare Advantage risk adjustment rules that exclude several high-margin diagnoses, with the changes first introduced three years ago and set to continue depressing revenue into 2026. As the largest provider with over eight million members, the company’s higher risk scores have amplified the financial hit relative to peers.
2. Regulatory Relief Measures
Regulators have postponed further payment adjustments and approved larger rate increases for 2027, offering partial relief to UnitedHealth’s reimbursement outlook. However, the company still faces a structurally less favorable payment environment that could limit future profit growth.
3. Cost Reduction Initiatives
Management is pursuing operational efficiencies within its Optum Health division by narrowing physician networks, consolidating electronic medical record systems and divesting clinic assets, alongside renegotiating contracts and shedding lower-margin members. These measures aim to offset the Medicare-related revenue decline and stabilize margins.
4. Earnings Outlook
UnitedHealth is targeting adjusted earnings above $17.75 per share for the year, reflecting only modest growth compared to prior performance levels. Investors will be watching whether cost-cutting actions and regulatory relief can drive a meaningful rebound in profit momentum.